PEPTIDE COMPOUND

To provide a novel peptide compound having high GLP-1 receptor/GIP receptor co-agonist activity and useful as an agent for the prophylaxis or treatment of obesity and the like.SOLUTION: The present invention provides H-Tyr-Aib-Glu-Gly-Thr-α-MePhe-Thr-Ser-Asp-Tyr-Aib-Lys-Tyr-Leu-Asp-Lys-Gln-Ala-Gln-A...

Full description

Saved in:
Bibliographic Details
Main Authors ASAMI TAIJI, NIIDA AYUMU
Format Patent
LanguageEnglish
Japanese
Published 01.11.2018
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:To provide a novel peptide compound having high GLP-1 receptor/GIP receptor co-agonist activity and useful as an agent for the prophylaxis or treatment of obesity and the like.SOLUTION: The present invention provides H-Tyr-Aib-Glu-Gly-Thr-α-MePhe-Thr-Ser-Asp-Tyr-Aib-Lys-Tyr-Leu-Asp-Lys-Gln-Ala-Gln-Ala-Glu-Phe-Val-Lys-Trp-Leu-Leu-Lys-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-Lys-NHor salt thereof.SELECTED DRAWING: None 【課題】高いGLP-1受容体/GIP受容体コアゴニスト活性を有し、肥満症などの予防・治療剤として有用な新規なペプチド化合物を提供する。【解決手段】H−Tyr−Aib−Glu−Gly−Thr−α-MePhe−Thr−Ser−Asp−Tyr−Aib−Lys−Tyr−Leu−Asp−Lys−Gln−Ala−Gln−Ala−Glu−Phe−Val−Lys−Trp−Leu−Leu−Lys−Gly−Gly−Pro−Ser−Ser−Gly−Ala−Pro−Pro−Pro−Ser−Lys−NH2またはその塩。【選択図】なし
Bibliography:Application Number: JP20180111494